Mead Johnson Nutrition said today (18 February) that it has closed its previously announced initial public offering of 30m shares of Class A common stock at the public offering price of US$24 per share.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Further, the underwriters of the offering have exercised their over-allotment option and purchased 4.5m additional shares of Class A common stock.
Including the over-allotment, the company sold 34.5m shares in the offering for net proceeds of around $782m, after deducting underwriting discounts, commissions and estimated offering expenses.
The company said that with this over-allotment, it will have 204.5m shares of Class A and Class B common stock outstanding.
Citi, Morgan Stanley, Banc of America Securities, Credit Suisse and JP Morgan acted as joint book-running managers for the offering.

US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData